Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Diabetes Care Devices Market, by Product
1.4.2 LAMEA Diabetes Care Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements : 2018, Oct – 2022, May) Leading Players
Chapter 4. LAMEA Diabetes Care Devices Market by Product
4.1 LAMEA Insulin Delivery Devices Market by Country
4.2 LAMEA Blood Glucose Monitoring Devices Market by Country
Chapter 5. LAMEA Diabetes Care Devices Market by Country
5.1 Brazil Diabetes Care Devices Market
5.1.1 Brazil Diabetes Care Devices Market by Product
5.2 Argentina Diabetes Care Devices Market
5.2.1 Argentina Diabetes Care Devices Market by Product
5.3 UAE Diabetes Care Devices Market
5.3.1 UAE Diabetes Care Devices Market by Product
5.4 Saudi Arabia Diabetes Care Devices Market
5.4.1 Saudi Arabia Diabetes Care Devices Market by Product
5.5 South Africa Diabetes Care Devices Market
5.5.1 South Africa Diabetes Care Devices Market by Product
5.6 Nigeria Diabetes Care Devices Market
5.6.1 Nigeria Diabetes Care Devices Market by Product
5.7 Rest of LAMEA Diabetes Care Devices Market
5.7.1 Rest of LAMEA Diabetes Care Devices Market by Product
Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Product Launches and Product Expansions:
6.2 DexCom, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Product Launches and Product Expansions:
6.2.5.3 Acquisition and Mergers:
6.3 Novo Nordisk A/S
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental & Regional Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Acquisition and Mergers:
6.4 Sanofi S.A.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Product Launches and Product Expansions:
6.5 Zealand Pharma A/S (Valeritas, Inc.)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Research & Development Expenses
6.5.4 Recent strategies and developments:
6.5.4.1 Product Launches and Product Expansions:
6.5.4.2 Approvals and Trials:
6.6 B. Braun Melsungen AG
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Bayer AG
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Approvals:
6.8 Abbott Laboratories
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Partnerships, Collaborations, and Agreements:
6.8.5.2 Approvals:
6.9 Ypsomed AG
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Recent strategies and developments:
6.9.4.1 Partnerships, Collaborations, and Agreements:
6.10. Arkray, Inc.
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Partnerships, Collaborations, and Agreements:
6.10.2.2 Geographical Expansions:



List of Tables

TABLE 1 LAMEA Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Diabetes Care Devices Market
TABLE 4 Product Launches And Product Expansions– Diabetes Care Devices Market
TABLE 5 Acquisition and Mergers– Diabetes Care Devices Market
TABLE 6 Geographical expansion– Diabetes Care Devices Market
TABLE 7 Approvals and Trials– Diabetes Care Devices Market
TABLE 8 LAMEA Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 9 LAMEA Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 10 LAMEA Insulin Delivery Devices Market by Country, 2018 - 2021, USD Million
TABLE 11 LAMEA Insulin Delivery Devices Market by Country, 2022 - 2028, USD Million
TABLE 12 LAMEA Blood Glucose Monitoring Devices Market by Country, 2018 - 2021, USD Million
TABLE 13 LAMEA Blood Glucose Monitoring Devices Market by Country, 2022 - 2028, USD Million
TABLE 14 LAMEA Diabetes Care Devices Market by Country, 2018 - 2021, USD Million
TABLE 15 LAMEA Diabetes Care Devices Market by Country, 2022 - 2028, USD Million
TABLE 16 Brazil Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 17 Brazil Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 18 Brazil Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 19 Brazil Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 20 Argentina Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 21 Argentina Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 22 Argentina Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 23 Argentina Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 24 UAE Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 25 UAE Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 26 UAE Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 27 UAE Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 28 Saudi Arabia Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 29 Saudi Arabia Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 30 Saudi Arabia Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 31 Saudi Arabia Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 32 South Africa Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 33 South Africa Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 34 South Africa Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 35 South Africa Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 36 Nigeria Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 37 Nigeria Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 38 Nigeria Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 39 Nigeria Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 40 Rest of LAMEA Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 41 Rest of LAMEA Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 42 Rest of LAMEA Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 43 Rest of LAMEA Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 44 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 45 Key Information – DexCom, Inc.
TABLE 46 Key information – Novo Nordisk A/S
TABLE 47 Key Information – Sanofi S.A.
TABLE 48 Key Information – Zealand Pharma A/S
TABLE 49 key Information – B. Braun Melsungen AG
TABLE 50 Key Information – Bayer AG
TABLE 51 Key Information – Abbott Laboratories
TABLE 52 Key Information –-Ypsomed AG
TABLE 53 Key Information – Arkray, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, collaborations and agreements : 2018, oct – 2022, may) Leading Players
FIG 5 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 6 Recent strategies and developments: DexCom, Inc.
FIG 7 Recent strategies and developments: Novo Nordisk A/S
FIG 8 Recent strategies and developments: Sanofi S.A.
FIG 9 Recent strategies and developments: Zealand Pharma A/S
FIG 10 Recent strategies and developments: Arkray, Inc.